{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:24Z","timestamp":1772119764680,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11033-021-06957-y","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T16:22:33Z","timestamp":1641399753000},"page":"1295-1301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Boqiang","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"issue":"7","key":"6957_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A et al (2008) Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 98(7):485\u2013489","journal-title":"J Surg Oncol"},{"issue":"6","key":"6957_CR2","first-page":"394","volume":"68","author":"FI Bray","year":"2018","unstructured":"Bray FI et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68(6):394\u2013424","journal-title":"CA: Cancer J Clin"},{"issue":"4","key":"6957_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt MA, Marcano-Bonilla L, Roberts LR (2019) Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol 8(4):2","journal-title":"Chin Clin Oncol"},{"issue":"2","key":"6957_CR4","first-page":"101","volume":"6","author":"CHE Lai","year":"2008","unstructured":"Lai CHE, Lau WY (2008) Gallbladder cancer\u2014a comprehensive review. Surg 6(2):101\u2013110","journal-title":"Surg"},{"key":"6957_CR5","doi-asserted-by":"publisher","first-page":"967472","DOI":"10.1155\/2015\/967472","volume":"2015","author":"R Kanthan","year":"2015","unstructured":"Kanthan R et al (2015) Gallbladder cancer in the 21st century. J Oncol 2015:967472","journal-title":"J Oncol"},{"issue":"18","key":"6957_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/atm.2019.08.67","volume":"7","author":"J Lin","year":"2019","unstructured":"Lin J et al (2019) Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice. Ann Transl Med 7(18):44","journal-title":"Ann Transl Med"},{"issue":"155","key":"6957_CR7","first-page":"255","volume":"28","author":"PK Haber","year":"2019","unstructured":"Haber PK, Sia D (2019) Translating cancer genomics for precision oncology in biliary tract cancers. Discov Med 28(155):255\u2013265","journal-title":"Discov Med"},{"issue":"9","key":"6957_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","volume":"7","author":"JW Valle","year":"2017","unstructured":"Valle JW et al (2017) New horizons for precision medicine in biliary tract cancers. Cancer Discov 7(9):943\u2013962","journal-title":"Cancer Discov"},{"issue":"8","key":"6957_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M et al (2014) Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet 46(8):872\u2013876","journal-title":"Nat Genet"},{"issue":"9","key":"6957_CR10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003\u20131010","journal-title":"Nat Genet"},{"issue":"12","key":"6957_CR11","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao Y et al (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45(12):1470\u20131473","journal-title":"Nat Genet"},{"key":"6957_CR12","doi-asserted-by":"publisher","first-page":"117955492094733","DOI":"10.1177\/1179554920947335","volume":"14","author":"L Li","year":"2020","unstructured":"Li L et al (2020) Genetic heterogeneity between paired primary and brain metastases in lung adenocarcinoma. Clin Med Insights Oncol 14:1179554920947335","journal-title":"Clin Med Insights Oncol"},{"key":"6957_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jtho.2020.10.128","volume":"16","author":"T Jiang","year":"2020","unstructured":"Jiang T et al (2020) Mutational landscape and evolutionary pattern of liver and brain metastasis in lung adenocarcinoma. J Thorac Oncol 16:237\u2013249","journal-title":"J Thorac Oncol"},{"issue":"2","key":"6957_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1073\/pnas.1814027116","volume":"116","author":"C Li","year":"2019","unstructured":"Li C et al (2019) Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proc Natl Acad Sci USA 116(2):619\u2013624","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"6957_CR15","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1158\/1078-0432.CCR-16-3115","volume":"23","author":"CKY Ng","year":"2017","unstructured":"Ng CKY et al (2017) Genetic heterogeneity in therapy-na\u00efve synchronous primary breast cancers and their metastases. Clin Cancer Res 23(15):4402\u20134415","journal-title":"Clin Cancer Res"},{"issue":"4","key":"6957_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.4925","volume":"242","author":"W Dai","year":"2017","unstructured":"Dai W et al (2017) Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma. J Pathol 242(4):500\u2013510","journal-title":"J Pathol"},{"key":"6957_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-8794-7-2","volume":"7","author":"L Ouyang","year":"2014","unstructured":"Ouyang L et al (2014) Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas. BMC Med Genomics 7:2","journal-title":"BMC Med Genomics"},{"issue":"12","key":"6957_CR18","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov LB et al (2015) Clock-like mutational processes in human somatic cells. Nat Genet 47(12):1402\u20131407","journal-title":"Nat Genet"},{"issue":"14","key":"6957_CR19","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754\u20131760","journal-title":"Bioinformatics"},{"issue":"16","key":"6957_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H et al (2009) The sequence alignment\/map format and SAMtools. Bioinformatics 25(16):2078\u20132079","journal-title":"Bioinformatics"},{"key":"6957_CR21","doi-asserted-by":"publisher","first-page":"14114","DOI":"10.1038\/ncomms14114","volume":"8","author":"JG Reiter","year":"2017","unstructured":"Reiter JG et al (2017) Reconstructing metastatic seeding patterns of human cancers. Nat Commun 8:14114","journal-title":"Nat Commun"},{"issue":"7","key":"6957_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41588-020-0628-z","volume":"52","author":"Z Hu","year":"2020","unstructured":"Hu Z et al (2020) Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet 52(7):701\u2013708","journal-title":"Nat Genet"},{"issue":"4","key":"6957_CR23","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E et al (2016) CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol 12(4):e1004873\u2013e1004873","journal-title":"PLoS Comput Biol"},{"issue":"6255","key":"6957_CR24","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.aab4082","volume":"349","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Campbell PJ (2015) Somatic mutation in cancer and normal cells. Science 349(6255):1483\u20131489","journal-title":"Science"},{"issue":"1","key":"6957_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12551-018-0415-6","volume":"11","author":"RC Poulos","year":"2019","unstructured":"Poulos RC, Wong JWH (2019) Finding cancer driver mutations in the era of big data research. Biophys Rev 11(1):21\u201329","journal-title":"Biophys Rev"},{"issue":"5","key":"6957_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I et al (2017) Universal patterns of selection in cancer and somatic tissues. Cell 171(5):1029-1041.e21","journal-title":"Cell"},{"issue":"7540","key":"6957_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N et al (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518(7540):495\u2013501","journal-title":"Nature"},{"issue":"3","key":"6957_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng.2891","volume":"46","author":"M Gerlinger","year":"2014","unstructured":"Gerlinger M et al (2014) Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 46(3):225\u2013233","journal-title":"Nat Genet"},{"issue":"2","key":"6957_CR29","first-page":"264","volume":"1855","author":"S Turajlic","year":"2015","unstructured":"Turajlic S, McGranahan N, Swanton C (2015) Inferring mutational timing and reconstructing tumour evolutionary histories. Biochim Biophys Acta 1855(2):264\u2013275","journal-title":"Biochim Biophys Acta"},{"issue":"19","key":"6957_CR30","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1158\/0008-5472.CAN-15-1889","volume":"75","author":"WS Hong","year":"2015","unstructured":"Hong WS, Shpak M, Townsend JP (2015) Inferring the origin of metastases from cancer phylogenies. Cancer Res 75(19):4021\u20134025","journal-title":"Cancer Res"},{"issue":"5","key":"6957_CR31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","volume":"68","author":"CP Wardell","year":"2018","unstructured":"Wardell CP et al (2018) Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 68(5):959\u2013969","journal-title":"J Hepatol"},{"issue":"1","key":"6957_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","volume":"73","author":"A Lamarca","year":"2020","unstructured":"Lamarca A et al (2020) Molecular targeted therapies: ready for \u201cprime time\u201d in biliary tract cancer. J Hepatol 73(1):170\u2013185","journal-title":"J Hepatol"},{"key":"6957_CR33","doi-asserted-by":"publisher","first-page":"101998","DOI":"10.1016\/j.ctrv.2020.101998","volume":"86","author":"A Athauda","year":"2020","unstructured":"Athauda A et al (2020) Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation. Cancer Treat Rev 86:101998","journal-title":"Cancer Treat Rev"},{"issue":"Suppl 1","key":"6957_CR34","doi-asserted-by":"publisher","first-page":"e000152","DOI":"10.1136\/esmoopen-2016-000152","volume":"2","author":"D Goldstein","year":"2017","unstructured":"Goldstein D, Lemech C, Valle J (2017) New molecular and immunotherapeutic approaches in biliary cancer. ESMO Open 2(Suppl 1):e000152","journal-title":"ESMO Open"},{"issue":"24","key":"6957_CR35","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1002\/cncr.30254","volume":"122","author":"M Javle","year":"2016","unstructured":"Javle M et al (2016) Biliary cancer: utility of next-generation sequencing for clinical management. Cancer 122(24):3838\u20133847","journal-title":"Cancer"},{"issue":"1","key":"6957_CR36","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-019-13420-x","volume":"10","author":"S Xu","year":"2019","unstructured":"Xu S et al (2019) Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun 10(1):5492","journal-title":"Nat Commun"},{"issue":"11","key":"6957_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41568-019-0185-x","volume":"19","author":"JG Reiter","year":"2019","unstructured":"Reiter JG et al (2019) An analysis of genetic heterogeneity in untreated cancers. Nat Rev Cancer 19(11):639\u2013650","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"6957_CR38","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/annonc\/mdx278","volume":"28","author":"Q Wei","year":"2017","unstructured":"Wei Q et al (2017) Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Ann Oncol 28(9):2135\u20132141","journal-title":"Ann Oncol"},{"issue":"11","key":"6957_CR39","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan L, Pantel K, Kang Y (2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19(11):1450\u20131464","journal-title":"Nat Med"},{"key":"6957_CR40","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.ctrv.2019.101936","volume":"84","author":"A Lamarca","year":"2020","unstructured":"Lamarca A et al (2020) Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat Rev 84:101936","journal-title":"Cancer Treat Rev"},{"key":"6957_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mrrev.2018.08.003","volume":"778","author":"R Mehrotra","year":"2018","unstructured":"Mehrotra R et al (2018) Genetic landscape of gallbladder cancer: global overview. Mutat Res-Rev Mutat Res 778:61\u201371","journal-title":"Mutat Res-Rev Mutat Res"},{"issue":"6","key":"6957_CR42","first-page":"668","volume":"6","author":"BE Sylvester","year":"2015","unstructured":"Sylvester BE, Vakiani E (2015) Tumor evolution and intratumor heterogeneity in colorectal carcinoma: insights from comparative genomic profiling of primary tumors and matched metastases. J Gastrointest Oncol 6(6):668\u2013675","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"6957_CR43","doi-asserted-by":"publisher","first-page":"e90459","DOI":"10.1371\/journal.pone.0090459","volume":"9","author":"SY Lee","year":"2014","unstructured":"Lee SY et al (2014) Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PLoS One 9(3):e90459","journal-title":"PLoS One"},{"issue":"11","key":"6957_CR44","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1158\/1078-0432.CCR-19-3507","volume":"26","author":"R Barroso-Sousa","year":"2020","unstructured":"Barroso-Sousa R et al (2020) Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1\/L1 blockade in metastatic triple-negative breast cancer. Clin Cancer Res 26(11):2565\u20132572","journal-title":"Clin Cancer Res"},{"issue":"11","key":"6957_CR45","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"AM Goodman","year":"2017","unstructured":"Goodman AM et al (2017) Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther 16(11):2598\u20132608","journal-title":"Mol Cancer Ther"},{"key":"6957_CR46","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.ctrv.2020.102084","volume":"89","author":"MG McNamara","year":"2020","unstructured":"McNamara MG et al (2020) Impact of high tumor mutational burden in solid tumors and challenges for biomarker application. Cancer Treat Rev 89:102084","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"6957_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2220\/biomedres.39.159","volume":"39","author":"K Hatakeyama","year":"2018","unstructured":"Hatakeyama K et al (2018) Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencing. Biomed Res 39(3):159\u2013167","journal-title":"Biomed Res"},{"issue":"1","key":"6957_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR et al (2017) Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med 9(1):34","journal-title":"Genome Med"},{"issue":"1","key":"6957_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/0008-5472.CAN-18-1086","volume":"79","author":"D Wang","year":"2019","unstructured":"Wang D et al (2019) Multiregion sequencing reveals the genetic heterogeneity and evolutionary history of osteosarcoma and matched pulmonary metastases. Cancer Res 79(1):7\u201320","journal-title":"Cancer Res"},{"issue":"1","key":"6957_CR50","doi-asserted-by":"publisher","first-page":"18900","DOI":"10.1038\/s41598-020-75844-6","volume":"10","author":"S Hallam","year":"2020","unstructured":"Hallam S et al (2020) The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden. Sci Rep 10(1):18900","journal-title":"Sci Rep"},{"issue":"5","key":"6957_CR51","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D et al (2015) Integrative clinical genomics of advanced prostate cancer. Cell 161(5):1215\u20131228","journal-title":"Cell"},{"issue":"7319","key":"6957_CR52","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature09460","volume":"467","author":"PJ Campbell","year":"2010","unstructured":"Campbell PJ et al (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467(7319):1109\u20131113","journal-title":"Nature"},{"issue":"7","key":"6957_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nm.3886","volume":"21","author":"LR Yates","year":"2015","unstructured":"Yates LR et al (2015) Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 21(7):751\u2013759","journal-title":"Nat Med"},{"issue":"5","key":"6957_CR54","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaoncol.2016.5630","volume":"3","author":"N Priedigkeit","year":"2017","unstructured":"Priedigkeit N et al (2017) Intrinsic subtype switching and acquired ERBB2\/HER2 amplifications and mutations in breast cancer brain metastases. JAMA Oncol 3(5):666\u2013671","journal-title":"JAMA Oncol"},{"issue":"7634","key":"6957_CR55","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini H et al (2016) Early dissemination seeds metastasis in breast cancer. Nature 540(7634):552\u2013558","journal-title":"Nature"},{"issue":"1","key":"6957_CR56","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1186\/s12885-020-07341-y","volume":"20","author":"Y Yang","year":"2020","unstructured":"Yang Y et al (2020) A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study. BMC Cancer 20(1):828","journal-title":"BMC Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06957-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06957-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06957-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T23:44:44Z","timestamp":1666482284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06957-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6957"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06957-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-815519\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"15 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflicts of interest for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Since this is an retrospective diagnostic study, no previous agreement from our Ethical Committee was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Additional declarations for articles in life science journals that report the results of studies involving humans and\/or animals.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}